Skip to Main Content

Paper Details

A randomized evaluation of the TriGuardâ¿¢ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
Eur Heart J
30
2021
Author NameAffiliation
Steven R Mess??Hospital of the University of Pennsylvania
John K ForrestYale School of Medicine, 135 College Street
  • 1 - 2

Datasets

Release 1.2